Xiamen Amoytop Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 545.3 million compared to CNY 419.31 million a year ago. Revenue was CNY 545.3 million compared to CNY 419.31 million a year ago.

Net income was CNY 128.81 million compared to CNY 84.17 million a year ago. Basic earnings per share from continuing operations was CNY 0.32 compared to CNY 0.21 a year ago. Diluted earnings per share from continuing operations was CNY 0.32 compared to CNY 0.21 a year ago.